Monalizumab (Anti-Human CD159a)
Product Specifications
CAS Number
1228763-95-8
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Monalizumab (Anti-Human CD159a) is a novel, first-in-class humanized immunoglobulin G4 monoclonal antibody immune checkpoint inhibitor that targets the inhibitory CD94/NKG2A receptors.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470029-500 1x 500 µL
Fibronectin (TV-1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470329-500 1x 500 µL
Small Cell Lung Cancer (SCLC) (MOC-52), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680891-500 1x 500 µL
Mucin 6 (MUC6) (CLH5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942094-100 1x 100 µL
P53 Tumor Suppressor Protein (rBP53-12), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details